✦ LIBER ✦

Disease-Free Survival at 2 or 3 Years Correlates With 5-Year Overall Survival of Patients Undergoing Radical Cystectomy for Muscle Invasive Bladder Cancer

✍ Scribed by Sonpavde, Guru; Khan, Myrna M.; Lerner, Seth P.; Svatek, Robert S.; Novara, Giacomo; Karakiewicz, Pierre I.; Skinner, Eila; Tilki, Derya; Kassouf, Wassim; Fradet, Yves; Dinney, Colin P.; Fritsche, Hans-Martin; Izawa, Jonathan I.; Bastian, Patrick J.; Ficarra, Vincenzo; Schoenberg, Mark; Sagalowsky, Arthur I.; Lotan, Yair; Shariat, Shahrokh F.

Book ID: 122697230
Publisher: Lippincott Williams and Wilkins
Year: 2011
Tongue: English
Weight: 260 KB
Volume: 185
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2010.09.110

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

530 EXTERNAL VALIDATION OF DISEASE-FREE

530 EXTERNAL VALIDATION OF DISEASE-FREE SURVIVAL AT 2 OR 3 YEARS AS A SURROGATE AND NEW PRIMARY ENDPOINT FOR PATIENTS UNDERGOING RADICAL CYSTECTOMY FOR MUSCLE INVASIVE UROTHELIAL CANCER OF THE BLADDER

✍ Bastian, Patrick J.; May, Matthias; Fritsche, Hans-Martin; Buchner, Alexander; B 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 179 KB

872 External validation of disease-free

872 External validation of disease-free survival at 2 or 3 years as a surrogate and new primary endpoint for patients undergoing radical cystectomy for muscle invasive urothelial carcinoma of the bladder

✍ H.M. Fritsche; M. May; M. Burger; P. Nuhn; W. Otto; A. Buchner; C. Bolenz; E. He 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 19 KB

External validation of disease-free surv

External validation of disease-free survival at 2 or 3 years as a surrogate and new primary endpoint for patients undergoing radical cystectomy for urothelial carcinoma of the bladder

✍ P. Nuhn; M. May; H.-M. Fritsche; A. Buchner; S. Brookman-May; C. Bolenz; R. Mori 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 336 KB